fluorodeoxyglucose f18 has been researched along with Fibrosarcoma in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksoy, SY; Asa, S; Erdoğan, EB; Halac, M; Ozhan, M | 1 |
| Choi, YY; Kim, JY; Yang, SO | 1 |
| Hu, K; Huang, T; Liang, X; Nie, D; Sun, T; Tang, G; Tang, X; Wang, H | 1 |
| Dai, M; Hu, W; Huo, L; Li, F; Luo, Y; Wu, H; Xue, H; Zhao, Y | 1 |
| Bol, A; Christian, N; De Bast, M; Grégoire, V; Jordan, B; Lee, JA | 1 |
| Hashimoto, M; Ito, K; Kubota, K; Masuda-Miyata, Y; Morooka, M; Wada, S; Yamasawa, K | 1 |
| Bormans, G; Cona, MM; de Witte, PA; Fonge, H; Li, J; Marysael, T; Ni, Y; Roskams, T; Van de Putte, M; Verbruggen, A | 1 |
| Chen, Z; Shi, X; Wang, X; Yi, C; Zhang, X | 1 |
| Ando, K; Hosoi, R; Inoue, O; Kobayashi, K; Koike, S; Momosaki, S; Nishimura, T | 1 |
| Gan, M; Luo, L; Tang, G; Tang, X; Wang, M | 1 |
| Chang, CH; Chen, CF; Chen, TJ; Fan, KH; Fu, YK; Hsu, WC; Jan, ML; Kao, PF; Lee, TW; Tsai, TH | 1 |
| Amitani, M; Hatazawa, J; Hosoi, R; Inoue, O; Matsuura, N; Shukuri, M; Takai, N | 1 |
| Chauhan, A; Chawla, M; Kumar, R; Vellimana, AK | 1 |
| Babsky, AM; Bansal, N; Hekmatyar, SK; Hutchins, GD; Zhang, H | 1 |
| Enomoto, K; Hamada, K; Hatazawa, J; Inohara, H; Kubo, T; Tamura, M; Tomita, Y | 1 |
| Griffiths, JR; Judson, IR; Leach, MO; McSheehy, PM | 1 |
| Börner, AR; Flügel, M; Knapp, WH; Kühnel, G; Redeker, J; Weckesser, E | 1 |
3 review(s) available for fluorodeoxyglucose f18 and Fibrosarcoma
| Article | Year |
|---|---|
PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions.
Topics: Adult; Biopsy; Bone Neoplasms; Chondrosarcoma; Fasciitis; Female; Fibrosarcoma; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Lymphoma; Multiple Myeloma; Musculoskeletal Diseases; Neoplasm Staging; Osteosarcoma; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
¹⁸F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma.
Topics: Adult; Biopsy; Diagnosis, Differential; Epithelioid Cells; Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Multimodal Imaging; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sclerosis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Role of PET/PET-CT in the management of sarcomas.
Topics: Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoma; Sarcoma, Ewing; Tomography, X-Ray Computed | 2006 |
14 other study(ies) available for fluorodeoxyglucose f18 and Fibrosarcoma
| Article | Year |
|---|---|
Appearance of recurrent cardiac myxofibrosarcoma on FDG PET/CT.
Topics: Adult; Fibroma; Fibrosarcoma; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Comparative uptake of ¹⁸F-FEN-DPAZn2, ¹⁸F-FECH, ¹⁸F-fluoride, and ¹⁸F-FDG in fibrosarcoma and aseptic inflammation.
Topics: Animals; Bacterial Infections; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fibrosarcoma; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Inflammation; Male; Metabolic Clearance Rate; Mice; Organ Specificity; Organometallic Compounds; Picolinic Acids; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Turpentine | 2014 |
The limitation of PET imaging for biological adaptive-IMRT assessed in animal models.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Disease Models, Animal; Fibrosarcoma; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Mice; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated | 2009 |
F-18 FDG PET/CT imaging of bulky myxofibrosarcoma in chest wall.
Topics: Aged; Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Male; Myxosarcoma; Positron-Emission Tomography; Thoracic Wall; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential.
Topics: Animals; Anthracenes; Autoradiography; Female; Fibrosarcoma; Fluorodeoxyglucose F18; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Necrosis; Neoplasms, Radiation-Induced; Perylene; Prognosis; Radionuclide Imaging; Random Allocation | 2012 |
18F-FDG PET/CT imaging of multiple myxofibrosarcoma in left upper abdomen and chest wall.
Topics: Abdominal Neoplasms; Fibroma; Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thoracic Wall; Tomography, X-Ray Computed; Young Adult | 2012 |
Enhancement of the relative uptake of 18F-FDG in mouse fibrosarcoma by rolipram.
Topics: Animals; Brain; Fibrosarcoma; Fluorodeoxyglucose F18; Heart; Hindlimb; Image Enhancement; Male; Mice; Mice, Inbred C3H; Muscle, Skeletal; Myocardium; Neoplasm Transplantation; Plasma; Radionuclide Imaging; Radiopharmaceuticals; Rolipram; Sensitivity and Specificity; Tissue Distribution | 2002 |
Synthesis and evaluation of O-(3-[18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer.
Topics: Animals; Fibrosarcoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Isotope Labeling; Mice; Myositis; Organ Specificity; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Tyrosine | 2003 |
Dynamic evaluation of 18F-FDG uptake by microPET and whole-body autoradiography in a fibrosarcoma-bearing mouse model.
Topics: Animals; Autoradiography; Female; Fibrosarcoma; Fluorodeoxyglucose F18; Mice; Models, Animal; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Distinct different intra-tumor distribution of FDG between early phase and late phase in mouse fibrosarcoma.
Topics: Animals; Disease Progression; Fibrosarcoma; Fluorodeoxyglucose F18; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2005 |
Monitoring chemotherapeutic response in RIF-1 tumors by single-quantum and triple-quantum-filtered (23)Na MRI, (1)H diffusion-weighted MRI and PET imaging.
Topics: Animals; Antineoplastic Agents; Diffusion Magnetic Resonance Imaging; Drug Monitoring; Fibrosarcoma; Fluorodeoxyglucose F18; Fluorouracil; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C3H; Radiopharmaceuticals; Sodium; Temperature; Time Factors; Tomography, Emission-Computed; Treatment Outcome; Tumor Cells, Cultured; Water | 2007 |
FDG PET imaging of myxofibrosarcoma on the sphenoid sinus.
Topics: Aged; Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Male; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sphenoid Sinus | 2008 |
Metabolites of 2'-fluoro-2'-deoxy-D-glucose detected by 19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Extracts; Fibrosarcoma; Fluorodeoxyglucose F18; Fluorouracil; Glucose-6-Phosphate Isomerase; Hexokinase; Isomerism; Isotopes; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Rhamnose; Treatment Outcome; Tumor Cells, Cultured | 2000 |
[Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography].
Topics: Aged; Carbon Radioisotopes; Diagnosis, Differential; Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tissue Distribution; Tomography, Emission-Computed | 2000 |